Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Mayo Clin Proc. 2017 Nov 3;92(12):1791–1799. doi: 10.1016/j.mayocp.2017.09.015

Table 3.

Relative risk of comorbidities and multimorbidity in 345 patients with Sarcoidosis in 1976–2013 compared to 345 subjects without Sarcoidosis according to time after incidence/index date

First 5 years only After 5 years only
Comorbidity Hazard ratio (95% CI)* Hazard ratio (95% CI)*
Hypertension 1.92 (1.04, 3.53) 1.02 (0.73, 1.42)
Congestive heart failure 18.33 (2.43, 138.53) 1.37 (0.79, 2.37)
Coronary artery disease 2.33 (0.96, 5.66) 1.38 (0.86, 2.23)
Arrhythmia 1.89 (0.92, 3.86) 1.34 (0.96, 1.88)
Hyperlipidemia 1.90 (1.18, 3.06) 1.06 (0.79, 1.42)
Cerebrovascular (stroke or transient ischemic attack) 10.06 (1.29, 78.67) 1.87 (1.00, 3.50)
Arthritis (rheumatoid arthritis or osteoarthritis) 2.36 (1.38, 4.03) 1.23 (0.91, 1.67)
Asthma 2.18 (0.82, 5.82) 1.50 (0.84, 2.69)
Cancer 0.78 (0.21, 2.92) 0.55 (0.28, 1.09)
Chronic kidney disease 2.08 (0.78, 5.54) 1.33 (0.82, 2.17)
Chronic obstructive pulmonary disease 2.03 (0.98, 4.21) 1.01 (0.65, 1.55)
Dementia/Alzheimer’s disease 1.50 (0.25, 8.97) 0.77 (0.35, 1.69)
Depression 2.00 (1.04, 3.85) 1.36 (0.87, 2.13)
Diabetes 1.02 (0.54, 1.91) 1.75 (1.24, 2.48)
Hepatitis -- --
Major osteoporotic fracture 3.15 (0.85, 11.66) 1.85 (0.96, 3.57)
Schizophrenia 2.15 (0.39, 11.76) 1.19 (0.46, 3.10)
Substance abuse disorder 1.55 (0.44, 5.49) 0.63 (0.29, 1.38)
≥2 chronic conditions 2.44 (1.58, 3.78) 1.34 (1.01, 1.77)
≥3 chronic conditions 1.59 (1.03, 2.45) 1.28 (0.98, 1.67)
≥4 chronic conditions 1.92 (1.21, 3.04) 1.26 (0.95, 1.67)
≥5 chronic conditions 3.40 (1.77, 6.55) 1.24 (0.92, 1.68)
*

adjusted for age, sex and calendar year of sarcoidosis/index date

Abbreviation: CI, confidence interval